The Application of [⁶⁸Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models

Table 1

Biodistribution analysis of comparing [¹⁸F]-FDG PET and [⁶⁸Ga]FAPI PET.

	^18F-FDG group			^68Ga-FAPI-04 group
	Mouse 1	Mouse 2	Mouse 3	Mouse 4	Mouse 5	Mouse 6
Tumor	5.74	7.51	4.58	8.82	4.58	6.86
Brain	9.13	11.34	13.45	0.93	2.19	1.32
Heart	12.45	16.06	14.01	0.51	0.62	0.83
Lungs	16.32	14.92	18.06	0.47	0.31	0.52
Liver	2.45	3.89	5.12	0.14	0.21	0.16
Bladder	10.12	8.66	13.34	14.18	13.48	9.56
Kidney	10.41	5.27	7.99	2.15	2.63	1.82
Muscle	1.41	1.32	1.24	1.2	0.92	0.71